MGB Alert® Bordetella pertussis & parapertussis ASR

MGB Alert B. pertussis & parapertussis, 48 rxn
The MGB Alert B. pertussis & parapertussis, 48 rxn consists of a ready to use 20x formulation for amplifying and detecting a region of the insertion sequences IS481 and IS1001 in B. pertussis and parapertussis. It is also biplexed with an Internal Control 1 probe and primer pair.

MGB Alert B. pertussis Positive Control, 100µL
The MGB Alert B. pertussis Positive Control, 100µL consists of a ready to use formulation with a concentration of 107 copies/µL and is designed for use with MGB Alert B. pertussis and parapertussis detection reagents.

MGB Alert B. parapertussis Positive Control, 100µL
The MGB Alert B. parapertussis Positive Control consists of a ready to use formulation with a concentration of 107 copies/µL and is designed for use with MGB Alert B. pertussis and parapertussis detection reagents.

MGB Alert Detection Reagents provide molecular labs a more advanced alternative for real-time PCR based assays. By using our MGB technology, combined with post-PCR dissociation melt curve analysis, Nanogen is able to provide molecular labs with powerful tools for detecting nucleic acid sequences of specific organisms or genetic mutations associated with disease, as well as enabling labs to probe molecular sequences that may not be accessible with other technologies.

MGB Alert Detection Reagents for specific analytes can be optimized for use with universal cycling parameters, most commercially available instruments, and supporting reagent systems. This facilitates easier implementation without additional capital investment for labs already set-up for real-time PCR.

The MGB Alert line includes ASRs for the detection of various pathogens including sequences associated with BK virus, Enterovirus, VZV, and others.

SmartCycler® is a register trademark of Cepheid.
Applied Biosystems® is a registered trademark of Applied Biosystems.
LightCycler® is a register trademark of Roche Diagnostics.